Загрузка...
Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal‐ and luminal‐like breast cancer xenografts
Several clinical trials have investigated the efficacy of bevacizumab in breast cancer, and even if growth inhibiting effects have been registered when antiangiogenic treatment is given in combination with chemotherapy no gain in overall survival has been observed. One reason for the lack of overall...
Сохранить в:
| Опубликовано в: : | Mol Oncol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528356/ https://ncbi.nlm.nih.gov/pubmed/22521242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2012.03.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|